Measuring lorazepam levels in adults with catatonia
Part of Brain & nervous system clinical trials.
This trial looks at adults with catatonia (a serious condition that affects movement and speech) and measures blood levels of lorazepam. It may help doctors better understand how the medicine behaves in the body for people receiving treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have catatonia diagnosed using DSM-5 criteria.
- You cannot be pregnant at the time of the study.
- You (or your legal guardian) must be willing to participate.
- You may be asked for blood samples to measure lorazepam levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for biological markers in the blood or spinal fluid that might predict how well a new psychiatric treatment will work. If you have a psychiatric condition that hasn't improved with previous treatments, this research could help find better ways to match treatments to individuals in the future.
This study looks at how often catatonic syndrome occurs in adults treated at Basurto Hospital, what other conditions it's linked to, and what happens in the short term. It helps doctors better understand this serious condition.
This study looks at the genes of children and teens with catatonia to understand why it happens and find better treatments. If your child has catatonia, you and your child may be able to join.
This study tests whether giving a low dose of lorazepam, a calming medicine, can help prevent delirium (confusion and agitation) in patients newly admitted to the intensive care unit (ICU). It may help patients recover more smoothly.
This study measures brain signals during scans to look for patterns linked to two types (subforms) of psychotic disorders. If you have schizophrenia or schizoaffective disorder and your symptoms have been stable, you may be able to help researchers understand these brain markers.
This study tests whether a new drug called brensocatib changes how the body processes midazolam, a medication commonly used for sedation. Healthy adults will take both drugs, and researchers will measure levels in the blood to see if brensocatib affects midazolam.
Hear when a new Catatonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.